Johnson & Johnson has received European Commission approval for nipocalimab, marketed as IMAAVY, as an add-on therapy for ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...

State Medicaid agencies are struggling to pay for an intensive therapy for children with autism — and looming federal cuts ...

Johnson & Johnson JNJ announced that the European Commission has approved Imaavy (nipocalimab) as an add-on therapy for the ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...

The world might look a little different than it did in the early 2000s — OK, a lot different — but the music that defined a ...

Beerse: Johnson & Johnson has announced that the European Commission has approved a Marketing Authorisation for IMAAVY ...

For many today, mental health isn’t just private—it’s public, performative, and yes, profitable. Social media platforms like ...

A man in his 50s known to have heart failure with left ventricular assist device presented after a suicide attempt by cutting the device’s driveline at home. This occurred in the context of functional ...

Trans advocacy groups are speaking out against the Greater Lehigh Valley Chamber of Commerce’s Lehigh Valley Healthcare Summit hosting Dr. Mehmet Oz.

Seven years ago, cancer patients forced to travel overseas for proton therapy were promised an Australian-based service — but ...

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel ...